Ignite Innovation Grant

Description

The goal of the Ignite Innovation program is to support the development and testing of transformative, paradigm-shifting, concepts and approaches to address critical barriers to progress in arthritis research, challenge our understanding of arthritis and its management, and generate novel approaches to confront the challenges we face in defeating arthritis and delivering the best evidence-informed care possible. The program intends to foster novel, high-potential projects and ideas that could be  expanded in the future  through additional funding sources (i.e., successful operating grants, industry partnership programs, cross discipline funding opportunities, etc.).

Successfully funded Ignite Innovation projects are based on “high risk” ideas that have a strong potential for “high reward”. The scope of high-risk projects could include proposals that focus on novel or untested tool development, cellular pathways, behavioural or psychosocial methodologies, research to address or ameliorate social or structural inequities, novel methods for delivering evidenced-based treatment or self-care interventions, unconventional devices or techniques/procedures (including measures) and/or have potential for unique translation. As projects are at an early stage of development, a high level of risk is expected and not all projects will yield anticipated results. High reward is defined as the potential to create a significant and real change or impact. Applicants must explain the anticipated change or impact that is likely to result and to whom or what will be affected by the change, and its significance. To support the novelty of the project, a thorough evaluation of the literature should be included. Applicants will be required to describe why the project is novel, as it relates to the latest methods, concepts, information, and techniques.

This program encourages bold attempts to test novel hypotheses and/or generate new knowledge and/or improvements related to prevention, detection, diagnosis, treatment, and support; therefore, while projects must be feasible and doable by the applicant(s), preliminary data is not necessary.

Applications are encouraged from all areas and disciplines of arthritis research, as well as from investigators in other disciplines whose ideas are relevant to the field of arthritis research. Diverse partnerships that advance and accelerate the application of the research are encouraged. These may include transdisciplinary research approaches and/or partnerships with industry, policy makers, consumers, health care providers and others. Note that the next logical step or incremental advancement on published data is notconsidered innovative and should not be submitted to this competition. 

This program supports different types of projects including, but not limited to, the following:

  • Pilot or feasibility studies;
  • Secondary analysis of existing data;
  • Small, self-contained research projects;
  • Development of research methodology; and
  • Development of new research technology.

Eligibility

To be considered eligible for this grant:

  • Applications must be submitted by an eligible Principal Investigator (PI) at an eligible Canadian Host institution as defined by the Arthritis Society.  The full description of eligibility, as well as the roles and responsibilities of the PI and HI in the management of the Arthritis Society’s research and training funds are defined on the Arthritis Society’s website.

Application

Applications must be submitted through the Arthritis Society’s online research grants portal 

See full requirements here 

Contact Name: 
oris@uleth.ca
Grant Amount: 
$50,000 annually for up to two years ($100,000)
Grant Location: 
External
External Deadline: 
Monday, May 16, 2022
Internal Deadline: 
Monday, May 9, 2022
Grant Type: 
Research
Grant Area: 
Health
Grant Eligibility: 
Faculty